• Screening MMV Compounds Reveals Antifungal Activity Against

  2026-05-21

  This study systematically screened the MMV Pandemic Response Box to identify compounds with in vitro activity against multidrug-resistant (MDR) bacterial and fungal clinical isolates, including Candida species. The findings highlight new antifungal candidates, demonstrate robust methodology for resistance screening, and inform future translational research on Candida infection management.

• GPER1 as a Chemopreventive Target in Prostate Cancer Progres

  2026-05-21

  This study establishes G-protein coupled estrogen receptor 1 (GPER1) as a critical suppressor of prostate cancer (PCa) progression, particularly at the high-grade prostatic intraepithelial neoplasia (HGPIN) stage. By integrating human samples, animal models, and mechanistic in vitro assays, the authors demonstrate that GPER1 activation halts tumorigenic transition, highlighting its therapeutic relevance.

• Stattic in STAT3 Pathway Research: Beyond Cancer to Inflamma

  2026-05-20

  Explore how Stattic, a potent STAT3 inhibitor, reveals new mechanistic insights in both cancer biology and inflammatory skin disorders. This article uniquely bridges oncology and immunology, leveraging recent breakthroughs to guide advanced experimental design.

• Aminopeptidase Inhibitors Reveal Angiotensin III as Active B

  2026-05-20

  This study demonstrates that Bestatin hydrochloride (Ubenimex), an inhibitor of aminopeptidase B, dramatically enhances angiotensin-evoked neuronal activity in the rat brain, supporting the hypothesis that angiotensin II must be converted to angiotensin III to exert central effects. These findings clarify peptide processing in neuroendocrine signaling and inform experimental approaches to cardiovascular and neurobiological research.

• Faropenem Sodium in Resistance Research: Mechanisms, Risks &

  2026-05-19

  Explore how Faropenem sodium, a penem antibiotic, enables advanced resistance research by combining broad-spectrum activity with mechanistic insights. This article critically examines its impact on antimicrobial resistance and provides actionable guidance for assay selection.

• Advancing Translational Immunotoxicology: Strategic ROS Assa

  2026-05-19

  Explore how advanced ROS detection—anchored by the APExBIO Reactive Oxygen Species (ROS) Assay Kit (DHE)—enables translational researchers to unravel redox-driven immunotoxicity mechanisms and design targeted interventions. Drawing on mechanistic insights, recent immunotoxicology findings, and best-practice workflows, this thought-leadership article delivers actionable guidance that bridges molecular discovery and preclinical application.

• STAT5B Overexpression Restores Myelin in Parkinson’s Models

  2026-05-18

  Li et al. (2025) reveal that oligodendrocyte-specific STAT5B overexpression mitigates myelin impairment and dopaminergic neuron loss in Parkinson’s disease (PD) models. This work uncovers a key epigenetic axis—DNMT3A-STAT5B-MBP—linking methylation-driven transcriptional repression to PD-associated myelin pathology, with broad implications for neurodegeneration research.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Evidence

  2026-05-18

  This Cochrane meta-analysis rigorously compares the efficacy and safety of toremifene and tamoxifen for advanced breast cancer. The review finds similar clinical outcomes between the two selective estrogen receptor modulators, informing therapeutic decision-making in hormone receptor-positive disease.

• TCF25 Orchestrates Lysosomal Cell Death Under Glucose Starva

  2026-05-17

  Ren et al. (2025) identify TCF25 as a critical nutrient sensor that modulates lysosomal acidification and triggers cell death via ferritinophagy in glucose-starved cells. These findings clarify the molecular link between metabolic adaptation and lysosome-dependent cell death, suggesting new avenues for targeting metabolic vulnerabilities in disease.

• Trelagliptin Succinate: Integrative Pathways in Diabetes and

  2026-05-16

  Explore the multifaceted scientific profile of Trelagliptin succinate—a selective DPP-4 inhibitor—examining its advanced mechanisms and unique potential in both type 2 diabetes and bone biology research. This article delivers a deeper, integrative analysis distinct from existing reviews.

• Oteseconazole (VT-1161): Applied Workflows for Candida Resea

  2026-05-15

  Oteseconazole (VT-1161) enables high-precision Candida susceptibility assays even in the face of fluconazole resistance and complex drug-drug interaction profiles. This article delivers step-by-step protocols, troubleshooting strategies, and translational insights to unlock the compound’s full potential in antifungal research and clinical modeling.

• hiPSC-Derived Intestinal Organoids for Human Pharmacokinetic

  2026-05-15

  This study presents a streamlined protocol to generate intestinal organoids from human pluripotent stem cells, offering a physiologically relevant in vitro model for pharmacokinetic investigations. The model addresses limitations of previous systems by supporting maturation and functional drug metabolism, enhancing translational relevance for gastrointestinal drug research.

• Oteseconazole (VT-1161): Advanced Antifungal Assay Strategie

  2026-05-14

  Oteseconazole (VT-1161) delivers potent, selective inhibition of Candida growth and stands out for its low risk of drug-drug interactions, enabling robust antifungal workflows. This article guides researchers in experimental design, troubleshooting, and maximizing data quality using Oteseconazole from APExBIO.

• Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Product

  2026-05-14

  This study systematically assesses low-cost microfluidic mixers and manual pipette mixing for producing lipid nanoparticles (LNPs) encapsulating mRNA, comparing physical properties and expression outcomes. The findings validate the suitability of budget-friendly microfluidic devices for bench-scale and high-throughput LNP-mRNA research, supporting broader accessibility and reproducibility in gene delivery studies.

• Dynasore: Applied Protocols for Dynamin GTPase Inhibition

  2026-05-13

  Dynasore empowers precise and reversible modulation of dynamin-dependent endocytosis, making it a gold-standard tool for dissecting vesicle trafficking and pathogen entry mechanisms. This article unpacks workflow optimizations, experimental troubleshooting, and evidence-driven guidance for leveraging Dynasore in cellular and infection models.

14729 records 1/982 page Next 12345 下5页 Last page